SurModics Valuation
| SRDXDelisted Stock | USD 42.98 0.00 0.00% |
At this time, the company appears to be overvalued. SurModics has a current Real Value of $33.27 per share. The regular price of the company is $42.98. Our model measures the value of SurModics from inspecting the company fundamentals such as Operating Margin of 0 %, return on equity of -0.15, and Shares Outstanding of 14.3 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that SurModics' price fluctuation is somewhat reliable at this time. Calculation of the real value of SurModics is based on 3 months time horizon. Increasing SurModics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SurModics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SurModics Stock. However, SurModics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 42.98 | Real 33.27 | Hype 44.17 |
The intrinsic value of SurModics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SurModics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of SurModics helps investors to forecast how SurModics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SurModics more accurately as focusing exclusively on SurModics' fundamentals will not take into account other important factors: SurModics Total Value Analysis
SurModics is at this time forecasted to have valuation of 614.37 M with market capitalization of 614.58 M, debt of 33.24 M, and cash on hands of 22.09 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the SurModics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
614.37 M | 614.58 M | 33.24 M | 22.09 M |
SurModics Investor Information
About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.24. SurModics had not issued any dividends in recent years. The entity had 2:1 split on the 7th of December 2000. Based on the key indicators related to SurModics' liquidity, profitability, solvency, and operating efficiency, SurModics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.SurModics Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of SurModics suggests not a very effective usage of assets in January.SurModics Ownership Allocation
The market capitalization of SurModics is $614.58 Million. The majority of SurModics outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in SurModics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in SurModics. Please pay attention to any change in the institutional holdings of SurModics as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.SurModics Profitability Analysis
The company reported the previous year's revenue of 126.08 M. Net Loss for the year was (11.54 M) with profit before overhead, payroll, taxes, and interest of 92.07 M.About SurModics Valuation
Our relative valuation model uses a comparative analysis of SurModics. We calculate exposure to SurModics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SurModics's related companies.Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. Surmodics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 389 people.
SurModics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 14.2 M | |
| Quarterly Earnings Growth Y O Y | 4.358 | |
| Forward Price Earnings | 208.3333 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in SurModics Stock
If you are still planning to invest in SurModics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SurModics' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |